arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC

$1.58 ▲ +0.04 (+2.92%) at close

16 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

NEUROONE MEDICAL TECHNOLOGIES Corp faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $63.4M

Dividend Yield —

Revenue Growth 163.5% ↗

Op. Margin -46.5% ↗

ROIC -47.2% ↗

FCF / Share $-0.07 ↗

Trailing P/E —

Price / Book 11.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

16-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$9.10M

↑ +163.5% —

Net Income Profit after all expenses

$-3.61M

↑ +70.7% —

Operating Margin Operating profit as % of sales

-46.5%

↑ +86.5% 5th

FCF / Share Free cash flow per share

$-0.07

↑ +82.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Sep 30, 2025 10-K ↗	FY 2024 Sep 30, 2024 10-K ↗	FY 2023 Sep 30, 2023 10-K ↗	FY 2022 Sep 30, 2022 10-K ↗	FY 2021 Sep 30, 2021 10-K ↗	FY 2020 Sep 30, 2020 10-K ↗	FY 2019 Sep 30, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Revenue Growth YoY (%)	163.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1943%)	76.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+861%)	1040.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+12908%)	-3.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-149%)	—	—	—	—	—	N/M	-4.0% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-150%)	-38.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-576%)	-84.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1152%)	13.2% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+65%)	496.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6108%)	—
EPS Growth YoY (%)	80.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	29.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-3.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	32.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	70.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-3.9% Weak ↓ Weak Declining Year-over-year change in net income	-18.6% Weak ↑ Weak Improving Year-over-year change in net income	-0.5% Weak ↑ Weak Improving Year-over-year change in net income	27.1% Excellent Excellent Year-over-year change in net income	-101.1% Weak Weak Year-over-year change in net income	—	—	—	24.0% Good ↑ Good Improving Year-over-year change in net income	-73.4% Weak ↓ Weak Declining Year-over-year change in net income	-18.6% Weak ↑ Weak Improving Year-over-year change in net income	39.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-38.3% Weak Weak Year-over-year change in net income	-502.7% Weak Weak Year-over-year change in net income	—
FCF Growth YoY (%)	82.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	43.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-50.3% Weak Weak Year-over-year change in free cash flow	39.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	N/M	N/M	—
Revenue CAGR 3Y (%)	276.0% Excellent Excellent Compound annual revenue growth over 3 years	168.6% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	-54.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-51.9% Weak Weak Compound annual revenue growth over 3 years	2.3% Caution Caution Compound annual revenue growth over 3 years	—	—	—
Revenue CAGR 5Y (%)	—	—	—	—	—	—	—	—	—	—	-8.7% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Sep 30, 2025 10-K ↗	FY 2024 Sep 30, 2024 10-K ↗	FY 2023 Sep 30, 2023 10-K ↗	FY 2022 Sep 30, 2022 10-K ↗	FY 2021 Sep 30, 2021 10-K ↗	FY 2020 Sep 30, 2020 10-K ↗	FY 2019 Sep 30, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Operating Margin (%) (%)	-46.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-410%)	-344.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2395%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-39.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-430%)	-356.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3073%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-32.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-322.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	463.9% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	-436.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.26x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—	0.91x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.89x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Sep 30, 2025 10-K ↗	FY 2024 Sep 30, 2024 10-K ↗	FY 2023 Sep 30, 2023 10-K ↗	FY 2022 Sep 30, 2022 10-K ↗	FY 2021 Sep 30, 2021 10-K ↗	FY 2020 Sep 30, 2020 10-K ↗	FY 2019 Sep 30, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Return on Invested Capital (%)	-47.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1142.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-151.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-82.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-123.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-187.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	371.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	22.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	47.4% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	80.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	65.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-39.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-221.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-147.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-78.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-128.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-103.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-1091.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-762.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-2657.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17519.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-4779.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-51.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-440%)	—	-189.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1365%)	-104.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-794%)	-151.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1112%)	—	—	—	—	42.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+180%)	77.1% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+414%)	102.4% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+583%)	100.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+572%)	292.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1849%)	—	139.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+832%)

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Sep 30, 2025 10-K ↗	FY 2024 Sep 30, 2024 10-K ↗	FY 2023 Sep 30, 2023 10-K ↗	FY 2022 Sep 30, 2022 10-K ↗	FY 2021 Sep 30, 2021 10-K ↗	FY 2020 Sep 30, 2020 10-K ↗	FY 2019 Sep 30, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Debt to Equity (x)	—	—	—	—	—	0.49x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-19%)	—	—	-0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-108%)	—	—	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	-3346.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-0.65x Weak Weak Operating income divided by interest expense Optimal: > 5x	-20.43x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-3.48x Weak Weak Operating income divided by interest expense Optimal: > 5x	-108.83x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-6.57M	$-1.46M	$-5.32M	$-8.16M	$-6.90M	$-3.03M	$-260.75K	$-13.26K	$253.00K	—	—	—	—	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	-0.21x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Sep 30, 2025 10-K ↗	FY 2024 Sep 30, 2024 10-K ↗	FY 2023 Sep 30, 2023 10-K ↗	FY 2022 Sep 30, 2022 10-K ↗	FY 2021 Sep 30, 2021 10-K ↗	FY 2020 Sep 30, 2020 10-K ↗	FY 2019 Sep 30, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Revenue per Share (USD)	$0.23	$0.13	$0.11	$0.01	$0.02	—	—	—	—	—	—	—	—	$0.00	$0.00	$0.00
Basic EPS, GAAP (USD)	$-0.09	$-0.46	$-0.65	$-0.63	$-0.93	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.07	$-0.42	$-0.73	$-0.49	$-0.81	—	—	—	—	—	—	—	—	$-0.01	$0.01	$-0.00
Book Value per Share (USD)	$0.14	$0.03	$0.26	$0.59	$0.55	$0.28	$-0.09	$-0.46	$-0.64	$-0.02	$-0.02	$-0.01	$-0.01	$-0.00	$-0.00	$-0.00
Tangible Book Value per Share (USD)	$0.14	$0.02	$0.26	$0.59	$0.53	$0.26	$-0.10	$-0.48	$-0.67	$-0.02	$-0.02	$-0.01	$-0.01	$-0.00	$-0.00	$-0.00
Basic Weighted Avg Shares (shares)	40.15M	26.76M	18.12M	16.00M	10.70M	—	—	—	—	—	—	—	—	5.07M	4.64M	4.29M

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Sep 30, 2025 10-K ↗	FY 2024 Sep 30, 2024 10-K ↗	FY 2023 Sep 30, 2023 10-K ↗	FY 2022 Sep 30, 2022 10-K ↗	FY 2021 Sep 30, 2021 10-K ↗	FY 2020 Sep 30, 2020 10-K ↗	FY 2019 Sep 30, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Working Capital (USD)	$7.92M	$2.42M	$5.52M	$9.08M	$6.11M	$1.80M	$-1.47M	$-3.78M	$-3.87M	—	$-81.49K	$-35.39K	$-30.29K	$-17.24K	$9.22K	$6.18K
Total Equity (USD)	$7.07M	$822.01K	$6.25M	$9.60M	$6.55M	$2.07M	$-1.24M	$-4.40M	$-5.04M	$-113.65K	$-81.49K	$-35.39K	$-30.29K	$-17.24K	$-3.28K	$-4.32K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Sep 30, 2025 10-K ↗	FY 2024 Sep 30, 2024 10-K ↗	FY 2023 Sep 30, 2023 10-K ↗	FY 2022 Sep 30, 2022 10-K ↗	FY 2021 Sep 30, 2021 10-K ↗	FY 2020 Sep 30, 2020 10-K ↗	FY 2019 Sep 30, 2019 10-K ↗	FY 2018 Sep 30, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Sales/Revenue/Turnover (USD)	$9.10M	$3.45M	$1.95M	$171.17K	$178.15K	—	—	—	—	$0.00	$742.00	$773.00	$1.25K	$7.88K	$6.96K	$1.17K
Depreciation Expense (USD)	$239.36K	$224.48K	$176.95K	$118.62K	$80.75K	$47.61K	$27.57K	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-3.61M	$-12.32M	$-11.86M	$-10.00M	$-9.95M	$-13.64M	$-6.78M	—	—	$-47.77K	$-62.86K	$-36.24K	$-30.55K	$-50.39K	$-36.43K	$-6.04K
Operating Cash Flow (USD)	$-2.84M	$-11.01M	$-12.89M	$-7.52M	$-8.60M	$-3.43M	$-5.40M	—	—	—	—	—	—	$-46.03K	$32.30K	$-5.09K

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 65 quarters

NEUROONE MEDICAL TECHNOLOGIES Corp

Analytical Summary

16-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare NMTC with peers